Common polymorphisms in CD44 gene and susceptibility to cancer: A systematic review and meta-analysis of 45 studies

Oncotarget

Volumn 7, Issue 46, 2016, Pages 76021-76035

  Zhang, Meng ^a   Wang, Yangyang ^a   Fang, Tingting ^a   Cai, Yangke ^b   Xu, Yue ^a   Yan, Cunye ^a   Zhang, Li ^a   Liang, Chaozhao ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

Author keywords

Cancer; CD44; Meta analysis; Polymorphism; Systematic review

Indexed keywords

HERMES ANTIGEN; CD44 PROTEIN, HUMAN; HYALURONIC ACID BINDING PROTEIN;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CD44 GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; RISK ASSESSMENT; ALLELE; CASE CONTROL STUDY; GENETIC ASSOCIATION STUDY; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; ODDS RATIO; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYALURONAN RECEPTORS; LINKAGE DISEQUILIBRIUM; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84996995577     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12580     Document Type: Article

References (32)

1. MPH RS, MS DNM, PhD AJD. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29.
2. Naor D, Sionov RV, Ish-Shalom D. CD44: Structure, Function and Association with the Malignant Process. Advances in Cancer Research. 1997; 71: 241-319.
3. Kunlabut K, Vaeteewoottacharn K, Wongkham C, Khuntikeo N, Waraasawapati S, Pairojkul C, Wongkham S. Aberrant Expression of CD44 in Bile Duct Cancer Correlates with Poor Prognosis. Asian Pacific Journal of Cancer Prevention. 2012; 13 Suppl: 95-9.
4. Fan CW, Wen L, Qiang ZD, Chen T, Zhou ZG, Mo XM, Hu JK. Prognostic significance of relevant markers of cancer stem cells in colorectal cancer-a meta analysis. Hepatogastroenterology. 2012; 59: 1421-7.
5. Kaufmann M, Minckwitz GV, Heider KH, Ponta H, Herrlich P, Sinn HP. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet. 1995; 345: 615-9.
6. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. Journal of Cell Biology. 1994; 124: 71-82.
7. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haußmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991; 65: 13-24.
8. Jijiwa M, Demir H, Gupta S, Leung C, Joshi K, Orozco N, Huang T, Yildiz VO, Shibahara I, Jesus JAD. CD44v6 Regulates Growth of Brain Tumor Stem Cells Partially through the AKT-Mediated Pathway. Plos One. 2011; 6: e24217-e.
9. Jiang L. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Research. 2012; 14: 1-12.
10. PhD MSM, FACS SYMP, Fuchs BC, FACS TFMP, PhD MKM, PhD CTM, PhD DKM, PhD MFM, Tanabe KK, FACS YKMP. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence. Journal of Surgical Oncology. 2015; 112: 622-8.
11. Wu XM, Yang HG, Zheng BA, Cao HF, Hu ZM, Wu WD. Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations. Plos One. 2015; 10.
12. Tulsyan S, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B. CD44 Gene Polymorphisms in Breast Cancer Risk and Prognosis: A Study in North Indian Population. Plos One. 2013; 8:: e71073.
13. Liu Y, Qing H, Su X, Wang C, Li Z, Liu S. Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis. Medical Science Monitor. 2014; 21: 2694-700.
14. Chou YE, Hsieh MJ, Chiou HL, Lee HL, Yang SF, Chen TY. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features. Biomed Research International. 2014; 2014: 231474-.
15. Ying-Erh Chou M-JH, Chung-Han Hsin, Whei-Ling Chiang, Yi-Cheng Lai, Yu-Hsien Lee, Shu-Ching Huang, Shun-Fa Yang, Chiao-Wen Lin. CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan. Plos One. 2014; 9: e93692.
16. Sharma KL, Yadav A, Gupta A, Tulsayan S, Kumar V, Misra S, Kumar A, Mittal B. Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population. Tumor Biology. 2013; 35: 2583-9.
17. Yadav A, Gupta A, Rastogi N, Agrawal S, Kumar A, Kumar V, Mittal B. Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival. Tumor Biology. 2015: 1-10.
18. Xiao M, Hu S, Zhang L, Huang J, Jiang H, Cai X. Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population. Mutagenesis. 2013; 28: 577-82.
19. Wu H, Deng J, Jian Z, You Y, Na L, Wei L, Wu D, Zhou Y. Functional polymorphisms in the CD44 gene and acute myeloid leukemia cancer risk in a Chinese population. Molecular Carcinogenesis. 2015; 54: 102-10.
20. Weng WC, Huang YH, Yang SF, Wang SS, Kuo WH, Hsueh CW, Huang CH, Chou YE. Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan. Tumour Biology. 2015: 1-7.
21. So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, Uskokovic M, Zheng X, Conney AH, Cai L. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Molecular Pharmacology. 2011; 79: 360-7.
22. Goodfellow PN, Banting G, Wiles MV, Tunnacliffe A, Parkar M, Solomon E, Dalchau R, Fabre JW. The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. European Journal of Immunology. 1982; 12: 659-63.
23. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proceedings of the National Academy of Sciences of the United States of America. 1992; 89: 12160-4.
24. Telen MJ, Udani M, Washington MK, Levesque MC, Lloyd E, Rao N. A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding. Journal of Biological Chemistry. 1996; 271: 7147-53.
25. Lopez JI, Camenisch TD, Stevens MV, Sands BJ, Mcdonald J, Schroeder JA. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Research. 2005; 65: 6755-63.
26. Bourguignon LYW. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. Journal of Mammary Gland Biology & Neoplasia. 2001; 6: 287-97.
27. Bourguignon LY, Singleton PA, Zhu H, Diedrich F. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. Journal of Biological Chemistry. 2003; 278: 29420-34.
28. Vazquez A, Grochola LF, Bond EE, Levine AJ, Taubert H, Müller TH, Würl P, Bond GL. Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. Cancer Research. 2010; 70: 172-80.
29. Thomas Winder YN, Dongyun Yang, Wu Zhang, Derek G Power, Pierre Bohanes, Armin Gerger, Peter M. Wilson, Georg Lurje, Laura H Tang, Manish Shah, Heinz-Josef Lenz. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma (GA). International Journal of Cancer. 2011; 129.
30. Shi J, Duan Y, Pan L, Zhou X. Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis. Oncotargets & Therapy. 2016; 9: 3493-500.
31. Bonferroni CE. Teoria Statistica Delle Classi e Calcolo Delle Probabilità. Comm Firenze. 1935: 216-8.
32. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263-5.